| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/07/2009 | US7557110 Pyrazolo[1,5-A] pyrimidine derivatives |
| 07/07/2009 | US7557083 Gastrokines and derived peptides including inhibitors |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/07/2009 | CA2425876C Piperidine derivatives as antagonists of tachykinins |
| 07/07/2009 | CA2422711C Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists |
| 07/07/2009 | CA2368165C Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 07/07/2009 | CA2304255C Hepatitis b virus polypeptides |
| 07/02/2009 | WO2009082426A1 Method of stimulating the motility of the gastrointestinal system using ipamorelin |
| 07/02/2009 | WO2009082348A1 Novel crystalline form c of (2r)-(3-amino-2-fluoropropyl)phosphinic acid |
| 07/02/2009 | WO2009082345A1 Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid |
| 07/02/2009 | WO2009082344A1 Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a |
| 07/02/2009 | WO2009082267A1 MEDICINAL AGENT FOR ANTI-Helicobacter THERAPY |
| 07/02/2009 | WO2009081833A1 Dried microorganism cell or microorganism extract containing stabilized (ss)-s-adenosyl-l-methionine, and method for production of the dried microorganism cell or microorganism extract |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009081611A1 Antibacterial agent and composition for the oral cavity, food and drink containing the same |
| 07/02/2009 | WO2009080828A2 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease |
| 07/02/2009 | WO2009080800A2 Method for decreasing abdominal girth by administering a bifidobacterium bacteria |
| 07/02/2009 | WO2009080351A1 Compounds with anti-emetic effect |
| 07/02/2009 | WO2009080030A1 Treatment of autoimmune hepatitis with a once daily oral dosage form comprising tacrolimus |
| 07/02/2009 | WO2009080006A2 Novel milk thistle extract, method for the production, and use |
| 07/02/2009 | WO2009079902A1 The preparation and use of a curcumin-zinc compound and its solid dispersion |
| 07/02/2009 | WO2009079860A1 Medicament for treating obesity or fatty liver disease |
| 07/02/2009 | WO2009079834A1 An anti-hcv vaccine and preparation methods and uses thereof |
| 07/02/2009 | WO2009079680A1 Use larch wood material for treating inflammation |
| 07/02/2009 | WO2009064819A3 Compositions for the treatment of gastrointestinal inflammation |
| 07/02/2009 | WO2009063364A3 Modulators of urotensin receptor and methods of use thereof |
| 07/02/2009 | WO2009063221A3 Methods of treating or preventing inflammatory diseases of the intestinal tract |
| 07/02/2009 | WO2009054737A9 Method of reducing greenhouse gas production |
| 07/02/2009 | WO2009043176A9 Herbal compositions and methods for treating hepatic disorders |
| 07/02/2009 | WO2009033678A3 Use of a tuftsin as a therapeutic agent |
| 07/02/2009 | US20090171086 2,4-pyrimidinediamine compounds and their uses |
| 07/02/2009 | US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170911 Novel azole compound |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170868 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 07/02/2009 | US20090170867 Trpv1 antagonists including sulfonamide substituent and uses thereof |
| 07/02/2009 | US20090170854 New Use |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs |
| 07/02/2009 | US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170763 Modified gherlin peptides |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169584 Treatment of sleep disturbances |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169515 Canine probiotic bifidobacteria globosum |
| 07/02/2009 | CA2747569A1 Use larch wood material for treating inflammation |
| 07/02/2009 | CA2709947A1 Novel milk thistle extract, method for preparation, and use |
| 07/02/2009 | CA2709913A1 Method of stimulating the motility of the gastrointestinal system using ipamorelin |
| 07/02/2009 | CA2708512A1 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/01/2009 | EP2075252A1 Nk1 receptor antagonist composition |
| 07/01/2009 | EP2074997A1 Use of Asimadoline for the treatment of digestive disorders |
| 07/01/2009 | EP2074995A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 07/01/2009 | EP2074105A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 07/01/2009 | EP2073831A1 Use of modified cyclosporins |
| 07/01/2009 | EP2073828A2 Composition to treat or prevent gastrointestinal infection |
| 07/01/2009 | EP2073799A2 Novel agents of calcium ion channel modulators |
| 07/01/2009 | EP1747006B1 Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug |
| 07/01/2009 | EP1675601B1 Moderating the effect of endotoxins |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1414428B1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
| 07/01/2009 | CN101469009A Methods and compositions for treating hepatitis c virus |
| 07/01/2009 | CN101468029A Difructose anhydride-containing composition and use thereof |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506844C Novel peptides |
| 07/01/2009 | CN100506821C Tetrahydropyridoethers |
| 07/01/2009 | CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506260C Compound preparation for treating mucosa ulceration |
| 07/01/2009 | CN100506242C Chinese medicine compound composition and method and use thereof |
| 07/01/2009 | CN100506234C Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn disease |
| 07/01/2009 | CN100506229C Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders |
| 07/01/2009 | CN100506226C Compound famotidine chewing tablet preparation method |
| 07/01/2009 | CN100506218C Spider aroma preparation for treating diarrhea and preparation method thereof |
| 06/30/2009 | US7553969 Substituted phenethylamine derivatives |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553856 Crystalline form of omeprazole |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553663 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553660 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
| 06/30/2009 | CA2286399C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 06/30/2009 | CA2057052C Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 06/25/2009 | WO2009078495A1 Insoluble dietary fiber-containing material originating in cereal seeds |
| 06/25/2009 | WO2009078444A1 Preventive or therapeutic agent for inflammatory bowel disease |
| 06/25/2009 | WO2009078432A1 1-alkyl-4-amino-1h-pyrazole-3-carboxamide compound |